Strategic Wealth Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Strategic Wealth Management Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$279K	Sell	4,173 -1,467	-26%	-$95.7K	0.1%	104
2021 Q1	$356K	Buy	5,640 +7	+0.1%	+$436	0.14%	90
2020 Q4	$349K	Buy	5,633 +187	+3%	+$11.5K	0.15%	79
2020 Q3	$328K	Buy	5,446 +1,441	+36%	+$86.7K	0.16%	77
2020 Q2	$235K	Buy	+4,005	New	+$240K	0.14%	81
2020 Q1	–	Sell	-3,693	Closed	-$237K	–	89
2019 Q4	$237K	Buy	+3,693	New	+$212K	0.15%	81
2019 Q1	–	Sell	-4,076	Closed	-$212K	–	82
2018 Q4	$212K	Buy	+4,076	New	+$219K	0.2%	71

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Strategic Wealth Management Group's BMY Position: Q2 2021 in Review

Strategic Wealth Management Group reduced its Bristol-Myers Squibb (BMY) stake by 26% in Q2 2021, selling an estimated $95.7K and leaving 4,173 shares worth $279K. The position accounts for 0.1% of the portfolio, ranked #104.

Strategic Wealth Management Group first reported a position in BMY in Q4 2018 and has held it in 7 quarters since. The position peaked at $356K in Q1 2021. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Strategic Wealth Management Group held 4,173 shares of Bristol-Myers Squibb worth $279K as of Q2 2021.
Strategic Wealth Management Group sold 1,467 Bristol-Myers Squibb shares in Q2 2021, an estimated $95.7K.
Bristol-Myers Squibb made up 0.1% of Strategic Wealth Management Group's portfolio in Q2 2021, its #104 holding.
Strategic Wealth Management Group first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 7 quarters since.
Strategic Wealth Management Group's Bristol-Myers Squibb position peaked at $356K in Q1 2021.
2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Strategic Wealth Management Group's 13F filing for Q2 2021, filed 13 Aug 2021.